A dual GIP/GLP-1 research peptide commonly submitted for blind identity and amount testing in public COA records.
Within this directory, Tirzepatide appears in 7 summarized public testing-style records across 14 supplier listings. All figures are informational snapshots and may change as records are updated.
| Product | Supplier | Testing Category | Reported Result | Record |
|---|---|---|---|---|
| Tirzepatide 20mg | HHM Peptide Ltd | GLP-1 blind test | Not publicly listed | 2025 |
| Tirzepatide 30MG | SSR | GLP-1 blind test | Not publicly listed | 2024 |
| Tirzepatide 30mg (TR30) | liliPeptide Technology | GLP-1 blind test | Not publicly listed | 2025 |
| Tirzepatide 120mg | ZLZ Peptides | Peptide vial assessment | Not publicly listed | 2024 |
| Tirzepatide 40mg | UWA Biotech | GLP-1 blind test | Not publicly listed | 2025 |
| Tirzepatide 20mg | Optimum Source Research | GLP-1 blind test | Not publicly listed | 2025 |
| Tirzepatide 30mg | HK Peptide Ltd | Peptide vial assessment | Not publicly listed | 2024 |
Tirzepatide is a research compound in the GLP-1 Research category. This page is informational and for research-use only; it does not provide dosage, human-use instructions, or medical claims.
Our directory currently summarizes 7 public testing-style records associated with Tirzepatide, across 14 supplier listings. Records are informational and may contain errors or omissions.
Look for a product name match, a batch or lot number, a testing date, the testing method (such as HPLC or LC-MS), and any publicly reported purity or amount. Missing fields can be a red flag.
No. Push for Peptides is an informational directory. It does not sell products, does not process payments, and does not provide medical advice. You can submit a supplier match request instead.
Submit a supplier match request and tell us what research-use product category you are looking for. Push for Peptides does not sell prescription medications and does not provide medical advice.